352 related articles for article (PubMed ID: 12757643)
1. [Impact of cyclin-dependent kinase inhibitor p27 on resistance of ovarian cancer multicellular spheroids to taxol].
Xing H; Li J; Gao QL; Wu JH; Gao C; Lu YP; Ma D
Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(1):37-41. PubMed ID: 12757643
[TBL] [Abstract][Full Text] [Related]
2. Effect of the cyclin-dependent kinases inhibitor p27 on resistance of ovarian cancer multicellular spheroids to anticancer chemotherapy.
Xing H; Wang S; Hu K; Tao W; Li J; Gao Q; Yang X; Weng D; Lu Y; Ma D
J Cancer Res Clin Oncol; 2005 Aug; 131(8):511-9. PubMed ID: 15924242
[TBL] [Abstract][Full Text] [Related]
3. Knock-down of P-glycoprotein reverses taxol resistance in ovarian cancer multicellular spheroids.
Xing H; Wang S; Weng D; Chen G; Yang X; Zhou J; Xu G; Lu Y; Ma D
Oncol Rep; 2007 Jan; 17(1):117-22. PubMed ID: 17143487
[TBL] [Abstract][Full Text] [Related]
4. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids.
Frankel A; Buckman R; Kerbel RS
Cancer Res; 1997 Jun; 57(12):2388-93. PubMed ID: 9192815
[TBL] [Abstract][Full Text] [Related]
5. [Resistance of multicellular spheroids to taxol in human ovarian cancer and its mechanism].
Xing H; Gao QL; Yang XK; Li J; Gao C; Wu JH; Lu YP; Ma D
Ai Zheng; 2003 Aug; 22(8):826-30. PubMed ID: 12917028
[TBL] [Abstract][Full Text] [Related]
6. [Experimental study on resistance to cisplatin and taxol in human ovarian cancer SKOV3ip1 multicellular aggregates].
Chen J; Feng Y; Zhou X
Zhonghua Fu Chan Ke Za Zhi; 2001 Aug; 36(8):489-92. PubMed ID: 11758187
[TBL] [Abstract][Full Text] [Related]
7. [Impact of hypoxia on taxol-induced apoptosis in human ovarian cancer cell line A2780 and its mechanism].
Huang L; Ao QL; Li F; Xing H; Lu YP; Ma D
Ai Zheng; 2005 Apr; 24(4):408-13. PubMed ID: 15820061
[TBL] [Abstract][Full Text] [Related]
8. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
Frankel A; Man S; Elliott P; Adams J; Kerbel RS
Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
[TBL] [Abstract][Full Text] [Related]
9. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.
Li Z; Hu S; Wang J; Cai J; Xiao L; Yu L; Wang Z
Gynecol Oncol; 2010 Oct; 119(1):125-30. PubMed ID: 20624637
[TBL] [Abstract][Full Text] [Related]
10. [Study of bcl-2 antisense oligodeoxynucleotides on reversal of cisplatin resistance in ovarian cancer cell line A2780/DDP].
Li M; Yu LL; Cai LQ; Wang HB; Wang ZH; Wang ZH
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):121-5. PubMed ID: 16640863
[TBL] [Abstract][Full Text] [Related]
11. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
Horowitz NS; Hua J; Gibb RK; Mutch DG; Herzog TJ
Gynecol Oncol; 2004 Jul; 94(1):67-73. PubMed ID: 15262121
[TBL] [Abstract][Full Text] [Related]
12. [Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines].
Yang XK; Xing H; Zheng F; Gao QL; Wang W; Lu YP; Ma D
Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):158-61. PubMed ID: 12816691
[TBL] [Abstract][Full Text] [Related]
13. Induced apoptosis in human prostate cancer cell line LNCaP by Ukrain.
Roublevskaia IN; Haake AR; Ludlow JW; Polevoda BV
Drugs Exp Clin Res; 2000; 26(5-6):141-7. PubMed ID: 11345020
[TBL] [Abstract][Full Text] [Related]
14. Oral antisense that targets protein kinase A cooperates with taxol and inhibits tumor growth, angiogenesis, and growth factor production.
Tortora G; Bianco R; Damiano V; Fontanini G; De Placido S; Bianco AR; Ciardiello F
Clin Cancer Res; 2000 Jun; 6(6):2506-12. PubMed ID: 10873106
[TBL] [Abstract][Full Text] [Related]
15. Effect of CD147 monoclonal antibody on paclitaxel resistance in HCE1 multicellular spheroids.
Hu Y; Wu Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 36(3):192-202. PubMed ID: 21464539
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line.
Wang NN; Zhao LJ; Wu LN; He MF; Qu JW; Zhao YB; Zhao WZ; Li JS; Wang JH
Asian Pac J Cancer Prev; 2013; 14(9):4983-8. PubMed ID: 24175763
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients.
Sonnemann J; Gänge J; Pilz S; Stötzer C; Ohlinger R; Belau A; Lorenz G; Beck JF
BMC Cancer; 2006 Jul; 6():183. PubMed ID: 16834771
[TBL] [Abstract][Full Text] [Related]
18. [Study of mdr1 antisense oligodeoxynucleotides on reversal of multidrug resistance in ovarian carcinoma cell line SKOV3].
Tong Y; Pan L; Zhou S
Zhonghua Fu Chan Ke Za Zhi; 2000 Nov; 35(11):677-9. PubMed ID: 11218898
[TBL] [Abstract][Full Text] [Related]
19. [Expression and significance of heparin binding-epidermal growth factor-like growth factor in paclitaxel-resistant ovarian cancer].
Tang X; Lu M; Li C; Deng S; Li M
Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):517-22. PubMed ID: 25327734
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of taxol in human head and neck tumors.
Gan Y; Wientjes MG; Schuller DE; Au JL
Cancer Res; 1996 May; 56(9):2086-93. PubMed ID: 8616855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]